Startup profile · funding coverage
Albert Invent funding, valuation and investors
Chemistry-native AI and data operating system for enterprise materials and formulation R&D.
Keep track of Albert Invent
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Series B
$55 million · October 13, 2026
Latest known valuation
Approximately $340 million, reported by Forbes
Series B · October 13, 2026
Total disclosed equity funding
$55M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
series b · Oakland, California, United States
Investors in latest funding
Lead: TCV
Other: Delta-v Capital , Socium Ventures , HighSage Ventures , Coral Capital , Legion VC , Coatue , J.P. Morgan Growth Equity Partners , Index Ventures , Applied Ventures
Overview
Oakland-based Albert Invent provides an AI-native operating system that captures experiments, structures chemical and materials data, and helps scientists search knowledge, design formulations and plan experiments.
Why Albert Invent is interesting
Albert is applying vertical AI to a data-heavy industrial workflow where failed experiments and tacit knowledge are often trapped in notebooks and spreadsheets.
Product & use cases
Albert OS combines structured experimental data, a chemistry ontology, workflow software and the Valence model. Ask Albert surfaces prior work, proposes formulations and assists with experiment design and analysis.
- Scientific knowledge retrieval
- Formulation design
- Experiment planning
- Materials R&D data management
Key facts
- $55 million Series B led by TCV.
- Approximately $340 million valuation reported by Forbes, not disclosed by the company.
- Project creation grew 26x year over year and scientist users grew 6x, according to Albert.
Funding history (newest first)
Series B
2026-10-13 $55 million Valuation: Approximately $340 million, reported by Forbes- TCV (lead)
- Delta-v Capital (participant)
- Socium Ventures (participant)
- HighSage Ventures (participant)
- Coral Capital (participant)
- Legion VC (participant)
- Coatue (participant)
- J.P. Morgan Growth Equity Partners (participant)
- Index Ventures (participant)
- Applied Ventures (participant)
Investors in our directory
Funds linked from Albert Invent's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: Its domain-specific ontology, proprietary chemistry model and enterprise deployment controls target scientific accuracy and governance gaps that general-purpose retrieval systems do not address.
Albert competes with laboratory informatics platforms, electronic lab notebooks and emerging AI-for-science vendors. Its commercial moat depends on deep integrations, proprietary customer data structures and proof that recommendations shorten R&D cycles without compromising traceability.
-
Benchling adjacent
Life-sciences R&D software incumbent with adjacent data and workflow capabilities.
-
Dotmatics incumbent
Scientific informatics incumbent serving laboratory R&D.
-
Periodic Labs adjacent
AI-for-science company pursuing automated scientific discovery.
Industries
Market / IPO context
Editorial / static context — not a live quote.
Related funding articles
Venture Capital Tracker pieces that cover Albert Invent's financing or category context.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.